Table 1.

Results of Immunophenotypic and Cytogenetic Analysis

Cell LineImmunophenotype (%)Karyotype*
TdtCD19CD10SmlgFMC7HLA-DRCD24
NALM-6 40 45 70 38 70 46, XY, t(5; 12)(q33; p12) [10] 
PBE-1 40 32 48 60 83 53 46, XY, t(5; 12)(q33; p12) [21] 
         47, XY, t(1; 10)(q21; q22), t(5; 12)(q33; p12), + 13 [5] 
LR-10.6 90 99 99 14 100 100 46, XY, t(5; 12)(q33; p12) [20] 
Cell LineImmunophenotype (%)Karyotype*
TdtCD19CD10SmlgFMC7HLA-DRCD24
NALM-6 40 45 70 38 70 46, XY, t(5; 12)(q33; p12) [10] 
PBE-1 40 32 48 60 83 53 46, XY, t(5; 12)(q33; p12) [21] 
         47, XY, t(1; 10)(q21; q22), t(5; 12)(q33; p12), + 13 [5] 
LR-10.6 90 99 99 14 100 100 46, XY, t(5; 12)(q33; p12) [20] 

T-cell markers CD2, CD4, and CD8, myeloid markers CD13 and CD33, and megakaryocytic marker CD41 were consistently negative in all three cell lines.

Abbreviations: Tdt, terminal deoxynucleotidyl transferase; Smlg, surface membrane Ig; cμ, cytoplasmic μ chain.

*

In square brackets: number of cells analyzed.

Combined CD19/CD10 staining.

Weak staining.

Close Modal

or Create an Account

Close Modal
Close Modal